Ramona Repaczki-Jones serves as the Executive Director, ATC Ops of Iovance Biotherapeutics, where she is focused on accelerating and scaling the transition of cell therapy products from clinical to the commercial setting.
In her role, Ramona bridges the gaps of traditional clinical trials with expertise in logistics and operations necessary for cell therapy. Her impact on a treatment center minimizes disruption while leveraging a collaborative approach to supporting innovative cell and gene portfolios. She brings over 15 years of experience in cell and gene therapy, treatment center operations, quality, chain of identity and chain of custody (COI/COC). Her experience spans academic cell therapy programs, non-profits, and industry settings.
She has led the development of academic service lines to onboard commercial therapies and was part of a cell therapy standards setting organization. Ramona’s work has supported various publications in the Biology of Blood and Marrow Transplantation, presentations at national and international conferences and innovative commercial COI/COC systems.